SYNB1934
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SYNB1934, covering 2022-10-17 to 2024-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3) [Phase 3]